Skip to main content
SpringerLink
Log in

Chronic myeloproliferative neoplasms

Second primary malignancies in myeloproliferative neoplasms and the role of aspirin

  • Correspondence
  • Published:
Leukemia Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Barbui T, Ghirardi A, Masciulli A, Carobbio A, Palandri F, Vianelli N, et al. Second cancer in Philadelphia negative myeloproliferative neoplasms (MPN-K). A nested case-control study. Leukemia. 2019;33(May 29):1996–2005.

    Article  CAS  PubMed  Google Scholar 

  2. Landolfi R, Marchioli R, Kutti J, Gisslinger H, Tognoni G, Patrono C, et al. Efficacy and safety of low-dose aspirin in polycythemia vera. New Engl J Med. 2004;350(Jan 8):114–24.

    Article  CAS  PubMed  Google Scholar 

  3. Bardou M, Barkun AN, Martel M, Chapelle N. Sa2019—chemoprevention of colorectal cancer in the general population: an umbrella metaanalysis. Gastroenterology. 2019;156:S–472.

    Article  Google Scholar 

  4. McNeil JJ, Nelson MR, Woods RL, Lockery JE, Wolfe R, Reid CM, et al. Effect of aspirin on all-cause mortality in the healthy elderly. New Engl J Med. 2018;379:1519–1528.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Hematology Department, University Hospital Dubrava, Zagreb, Croatia

    Marko Lucijanic & Rajko Kusec

  2. Pharmacy Department, General Hospital Sibenik, Sibenik, Croatia

    Marko Skelin

  3. Division of Molecular Diagnosis and Genetics, Clinical Department of Laboratory Diagnostics, University Hospital Dubrava, Zagreb, Croatia

    Rajko Kusec

  4. School of Medicine, University of Zagreb, Zagreb, Croatia

    Rajko Kusec

Authors
  1. Marko Lucijanic
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marko Skelin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rajko Kusec
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Marko Lucijanic.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lucijanic, M., Skelin, M. & Kusec, R. Second primary malignancies in myeloproliferative neoplasms and the role of aspirin. Leukemia 33, 2554 (2019). https://doi.org/10.1038/s41375-019-0553-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41375-019-0553-2

  • Springer Nature Limited

This article is cited by

Search

Navigation